太极集团：公司关注并重视在资本市场的表现

Core Viewpoint - Taiji Group emphasizes its commitment to maintaining shareholder interests and enhancing investor confidence through strategic actions in the capital market [2] Group 1: Company Actions - The company held the 30th meeting of the 10th Board of Directors on July 16, 2025, and the second extraordinary general meeting of shareholders on August 6, 2025, to review and approve relevant proposals [2] - On September 22, 2025, the company completed a share buyback, utilizing a total of 120 million yuan [2] Group 2: Future Plans - The company plans to consider various factors such as market conditions, regulatory requirements, and investor needs to fulfill its responsibilities as a listed company [2] - Taiji Group aims to strengthen compliance information disclosure, focus on the pharmaceutical and health sector, accelerate technological innovation, improve corporate governance, and enhance investor relations management [2]